BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4067853)

  • 1. Analysis of the variance components in a pharmaceutical aerosol product: lodoxamide tromethamine.
    Havel HA; Beaubien LJ; Haaland PD
    J Pharm Sci; 1985 Sep; 74(9):978-82. PubMed ID: 4067853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of lodoxamide in plasma using ion-pairing and reversed-phase high-performance liquid chromatography.
    Honigberg IL; Stewart JT; Ewing BJ; Taylor WD
    J Chromatogr; 1983 Aug; 276(1):213-7. PubMed ID: 6672016
    [No Abstract]   [Full Text] [Related]  

  • 5. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL; Clark RE
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
    Veal CF; Jackson RM; Brannen AL; Fulmer JD
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
    McGregor JA; Levin MJ; Masters H
    J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
    [No Abstract]   [Full Text] [Related]  

  • 11. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
    Parrish RW; Davies BH
    Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
    Knoop FC; Thomas DD
    Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lodoxamide on ischemic reperfused myocardium.
    Jolly SR; Abrams GD; Romson JL; Bailie MB; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(3):441-8. PubMed ID: 6177941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
    Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S; Graham VA; Bentley S; Davies RJ
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.